Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1V-fend----1件: 299 💬
2V08ca02----1件: 13 💬
3V08ca09----1件: 13 💬
4V117957----1件: 226 💬
5V1512 and entacapone----1件: 6 💬
6V565----2件: 96, 97 💬
7V81444----1件: 6 💬
8Vaccin grippal pandémique H1n1----1件: 299 💬
9Vaccination----1件: 49 💬
10Vaccination against cholera----1件: 97 💬
11Vaccination against TBE----1件: 46 💬
12Vaccination with 2 doses OF shingrix vaccine----2件: 41, 51 💬
13Vaccination with vaccine against hepatitis A and B----1件: 299 💬
14Vaccine----6件: 46, 49, 51, 96, 97, 271 💬
15Vaccine ANTI-H1n1----1件: 97 💬
16Vaccine vivotif + vaccine dukoral + oats----1件: 97 💬
17Vaccino contro IL memingococco DI gruppo B----3件: 61, 62, 66 💬
18Vaccino haemophilus influenzae B coniugato CON proteina difterica CRM197----1件: 62 💬
19Vaccino haemophilus influenzae B coniugato CON tossoidetetanico----3件: 61, 62, 66 💬
20Vaccino meningococcico polisaccaridico----1件: 62 💬
21Vaccino pneumococcico----2件: 62, 66 💬
22Vaccino pneumococcico saccaridico----1件: 14 💬
23VAD044 part I1件: VAD-044---1件: 227 💬
24VAD044 part II1件: VAD-044---1件: 227 💬
25Vaginal estriol----1件: 13 💬
26Vaginal estrogen----1件: 226 💬
27VAL-1221----2件: 256, 309 💬
28Valbenazine1件: Valbenazine2件: Valbenazine ,
Valbenazine tosylate 💬 		1件: SLC18A1_2 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
29Valdecoxib1件: Valdecoxib---1件: 46 💬
30Valerian1件: Valerian1件: Japanese valerian 💬 --1件: 6 💬
31Valganciclovir1件: Valganciclovir2件: Valganciclovir ,
Valganciclovir hydrochloride 💬 		--6件: 28, 60, 85, 97, 299, 331 💬
32Valiloxybate1件: Valiloxibic acid1件: Valiloxybate 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
33Valine1件: Valine1件: Valine 💬 --1件: 244 💬
34Valproate1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 90 💬
35Valproate sodium1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
36Valproate, levocarnitine1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
37Valproic acid1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
38Valproic acid and levocarnitine1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
39Valproid acid plus corticosteroids----1件: 26 💬
40Valsacor----2件: 167, 168 💬
41Valsalva----1件: 58 💬
42Valsartan1件: Valsartan1件: Valsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬7件: 57, 58, 66, 75, 210, 222, 224 💬
43Valsartan 40 MG1件: Valsartan1件: Valsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
44Valsartanum 40 MG / placebo 1----2件: 167, 168 💬
45Valsartanum 80 MG / placebo 2----2件: 167, 168 💬
46Valzek----2件: 167, 168 💬
47Vamarolone----1件: 113 💬
48Vaminolac----1件: 97 💬
49Vamorolone1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
50Vamorolone 0.25 MG/DAY/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
51Vamorolone 0.25 MG/KG/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
52Vamorolone 0.75 MG/DAY/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
53Vamorolone 0.75 MG/KG/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
54Vamorolone 2.0 MG/DAY/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
55Vamorolone 2.0 MG/KG/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
56Vamorolone 4% suspension FOR oral dosing1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
57Vamorolone 40 MG/ML oral suspension1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
58Vamorolone 6.0 MG/DAY/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
59Vamorolone 6.0 MG/KG/DAY1件: Vamorolone1件: Vamorolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
60Vancomicina cloridrato1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--2件: 94, 97 💬
61Vancomycin1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--8件: 13, 46, 70, 94, 96, 97, 296, 299 💬
62Vancomycin hydrochloride inhalation powder1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 299 💬
63Vancomycin inhalation powder1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 299 💬
64Vancomycin oral capsule1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 97 💬
65Vancomycin PRE-treat1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 97 💬
66Vancomycin PRE-treatment1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 97 💬
67Vancomycin, mupirocin ointment1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 97 💬
68Vanzacaftor1件: Vanzacaftor1件: Vanzacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
69Vardenafil1件: Vardenafil2件: Vardenafil ,
Vardenafil hydrochloride 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬3件: 13, 86, 299 💬
70Vardenafilo hidrocloruro1件: Vardenafil2件: Vardenafil ,
Vardenafil hydrochloride 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 13 💬
71Varenicline1件: Varenicline2件: Varenicline tartrate ,
Varenicline 💬 		2件: CHRNA4,
CHRNB2 💬 		5件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬2件: 6, 18 💬
72Varenicline nasal spray1件: Varenicline2件: Varenicline tartrate ,
Varenicline 💬 		2件: CHRNA4,
CHRNB2 💬 		5件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬1件: 53 💬
73Varenicline tartrate1件: Varenicline2件: Varenicline tartrate ,
Varenicline 💬 		2件: CHRNA4,
CHRNB2 💬 		5件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬1件: 6 💬
74Vari----2件: 62, 274 💬
75Variation OF behaviors OF parkinson'S disease----1件: 6 💬
76Varicella zoster vaccine----1件: 46 💬
77Various----1件: 95 💬
78Vascular ultrasound----1件: 41 💬
79Vasculopathy assessment----1件: 51 💬
80Vaseline----1件: 51 💬
81Vasomera (PB1046) injection1件: Vasomera---1件: 86 💬
82Vasopressin1件: Vasopressin1件: Vasopressin 💬 3件: AVPR1A,
AVPR1B,
AVPR2 💬 		6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬2件: 210, 225 💬
83Vasopressin, arginine1件: Vasopressin1件: Vasopressin 💬 3件: AVPR1A,
AVPR1B,
AVPR2 💬 		6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 210 💬
84Vastarel----2件: 2, 58 💬
85Vastarel 20MG film coated tablets----1件: 58 💬
86Vatelizumab1件: Vatelizumab---2件: 13, 97 💬
87Vatiquinone1件: Vatiquinone1件: Vatiquinone 💬 --2件: 18, 21 💬
88Vaxzevria suspension FOR injection covid-19 vaccine (chadox1-S1件: AstraZeneca COVID-19 Vaccine---1件: 299 💬
89VAY736----9件: 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
90VAY736 1ML PFS----2件: 46, 49 💬
91VAY736 2 ML PFS----2件: 46, 49 💬
92VAY736 2ML AI----2件: 46, 49 💬
93VAY736 antibody----1件: 53 💬
94VAY736 higher dose----1件: 53 💬
95VAY736 lower dose----1件: 53 💬
96VB-2011件: VB-201---1件: 97 💬
97VB-201 160MG1件: VB-201---1件: 97 💬
98VB119----1件: 222 💬
99VB13s1----1件: 13 💬
100VB5s2----1件: 13 💬
101VB6s5----1件: 13 💬
102VBP15----1件: 113 💬
103VC005 tablets----2件: 46, 271 💬
104VE202----1件: 97 💬
105Vector viral adenoasociado DE serotipo 9 QUE contiene EL GEN DE LA sulfamidasa humana----1件: 19 💬
106Vectra mbda test----1件: 46 💬
107Vedolizumab1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬3件: 94, 96, 97 💬
108Vedolizumab 108 MG SC1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
109Vedolizumab 300 MG1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
110Vedolizumab 300 MG IV1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
111Vedolizumab injection1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
112Vedolizumab intravenous injection1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
113Vedolizumab IV1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬3件: 94, 96, 97 💬
114Vedolizumab IV 300 MG1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 96 💬
115Vedolizumab SC1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
116Vedolizumab SC 108 MG1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
117Vedolizumab subcutaneous injection1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
118Vedolizumab, entyvio1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
119Vedolizumab, ustekinumab, or tofacitinib1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
120Vedrop----1件: 299 💬
121Vedulizumab----1件: 97 💬
122Vegan diet----1件: 46 💬
123Vegan drink----1件: 97 💬
124Vegetable OIL----1件: 257 💬
125Vegetarian meat alternative----1件: 97 💬
126Vegetarian yogurt----1件: 97 💬
127Vehice control----1件: 96 💬
128Vehicle----5件: 6, 36, 53, 160, 192 💬
129Vehicle control----2件: 36, 53 💬
130Vehicle cream----1件: 36 💬
131Vehicle EYE drops----1件: 90 💬
132Vehicle GEL----2件: 13, 34 💬
133Vehicle OF ADX-102 topical dermal cream----1件: 160 💬
134Vehicle ophthalmic solution----1件: 53 💬
135Vehicle topical GEL----1件: 36 💬
136Velaglucerase alfa1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
137Velaglucerasi alfa----1件: 19 💬
138Velamox----1件: 11 💬
139Velcade1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
140Velcade*1FL 3,5MG1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
141Velcade*EV 1FL 3,5MG 1MG/ML----1件: 61 💬
142Veledimex1件: Veledimex1件: Veledimex 💬 --1件: 51 💬
143Velmanase alfa1件: Velmanase alfa1件: Velmanase alfa 💬 1件: MAN2B1 💬 2件: Lysosome, Other glycan degradation 💬1件: 19 💬
144Veltuzumab1件: Veltuzumab1件: Veltuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 46, 63 💬
145Veltuzumab solution 75MG/ML1件: Veltuzumab1件: Veltuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
146Velusetrag1件: Velusetrag1件: Velusetrag 💬 1件: HTR4 💬 5件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬1件: 99 💬
147Venetoclax1件: Venetoclax1件: Venetoclax 💬 1件: BCL2 💬 40件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬2件: 28, 85 💬
148Venetoclax MTD with dexamethasone2件: Dexamethasone,
Venetoclax		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Venetoclax 💬 		2件: BCL2,
NR3C1 💬 		41件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
149Venetoclax oral tablet, 200 MG1件: Venetoclax1件: Venetoclax 💬 1件: BCL2 💬 40件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
150Venetoclax oral tablet, 400 MG1件: Venetoclax1件: Venetoclax 💬 1件: BCL2 💬 40件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
151Venglustat1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬2件: 19, 67 💬
152Venglustat GZ/SAR4026711件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬2件: 6, 67 💬
153Venglustat GZ4026711件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬2件: 19, 67 💬
154Venglustat L-malate1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
155Venglustat malate1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬3件: 6, 19, 67 💬
156Venglustat malato1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬2件: 19, 67 💬
157Venipunctures----1件: 84 💬
158Venlafaxin hexal----1件: 13 💬
159Venlafaxine1件: Venlafaxine3件: Venlafaxine hydrochloride ,
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 97 💬
160Venlafaxine hydrochloride1件: Venlafaxine3件: Venlafaxine hydrochloride ,
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 13, 46 💬
161Venofer1件: Iron sucrose1件: Iron sucrose 💬 --1件: 97 💬
162Venofer solution FOR injection, 100 MG iron1件: Iron sucrose1件: Iron sucrose 💬 --1件: 97 💬
163Venofer solution FOR injection, 20 MG iron/ML1件: Iron sucrose1件: Iron sucrose 💬 --1件: 97 💬
164Venofer solution FOR injection, 20 MG/ML iron1件: Iron sucrose1件: Iron sucrose 💬 --1件: 97 💬
165Venous blood sample----1件: 46 💬
166VENT-02----1件: 6 💬
167Ventavis1件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
168Ventavis 101件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
169Ventilatory/ respiratory and other support assessment----1件: 113 💬
170Ventoline oral solution 0,4MG/ML----1件: 111 💬
171Ventoline tablet 2MG----1件: 111 💬
172Ventolin® evohaler1件: Albuterol2件: Albuterol sulfate ,
Albuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
173Ventrix BIO extracellular matrix----1件: 211 💬
174Venus versa----1件: 265 💬
175Verapamil1件: Verapamil2件: Verapamil hydrochloride ,
Verapamil 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 58, 96, 140, 167 💬
176Verapamil hydrochloride1件: Verapamil2件: Verapamil hydrochloride ,
Verapamil 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
177Verapamil SR1件: Verapamil2件: Verapamil hydrochloride ,
Verapamil 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
178Verapamil tablet1件: Verapamil2件: Verapamil hydrochloride ,
Verapamil 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
179Verdiperstat1件: Verdiperstat1件: Verdiperstat 💬 1件: MPO 💬 5件: Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬2件: 17, 127 💬
180Verenafusp alfa 12 MG/KG----1件: 19 💬
181Verenafusp alfa 6 MG/KG----1件: 19 💬
182Verenafusp alfa 9 MG/KG----1件: 19 💬
183Vericiguat1件: Vericiguat1件: Vericiguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
184Verorab® (pvrv----1件: 65 💬
185Verum ARM receiving vitamin D OIL----1件: 13 💬
186VES001----1件: 127 💬
187Vesanoid1件: Tretinoin1件: Tretinoin 💬 3件: PML,
RARA,
RARB 💬 		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 75 💬
188Vesemnogene lantuparvovec----1件: 3 💬
189Vesicare 10MG tablet----1件: 13 💬
190Vesleteplirsen1件: Vesleteplirsen---1件: 113 💬
191Vestibular habituation exercises----1件: 13 💬
192Vestibular rehabilitation: balance and EYE movement exercises----1件: 13 💬
193Vestibular/balance assessment----1件: 122 💬
194Vestronidase alfa1件: Vestronidase alfa1件: Vestronidase alfa 💬 1件: uidA 💬 6件: Ascorbate and aldarate metabolism, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19 💬
195Vett lentiviral CON gene ABCA4----1件: 301 💬
196Veyondi 650IU powder and solvent FOR solution FOR injection----1件: 288 💬
197Veyvondi----1件: 288 💬
198Veyvondi 1300 IU powder and solvent FOR solution FOR injection1件: Vonicog alfa1件: Vonicog alfa 💬 --1件: 288 💬
199Veyvondi 1300I IU powder and solvent FOR solution FOR injection1件: Vonicog alfa1件: Vonicog alfa 💬 --1件: 288 💬
200Veyvondi 1300IU1件: Vonicog alfa1件: Vonicog alfa 💬 --1件: 288 💬
201Veyvondi 1300IU powder and solvent FOR solution FOR injection1件: Vonicog alfa1件: Vonicog alfa 💬 --1件: 288 💬
202Veyvondi 650IU1件: Vonicog alfa1件: Vonicog alfa 💬 --1件: 288 💬
203Veyvondi 650IU powder and solvent FOR solution FOR injection1件: Vonicog alfa1件: Vonicog alfa 💬 --1件: 288 💬
204Vfend1件: Voriconazole1件: Voriconazole 💬 --1件: 299 💬
205Vfend 40 MG/ML powder FOR oral suspension1件: Voriconazole1件: Voriconazole 💬 --1件: 299 💬
206VG901----1件: 90 💬
207VGA0391件: VGA039---1件: 288 💬
208VGB-ST soluble tablets----1件: 145 💬
209VGN-R08B----1件: 19 💬
210VGN-R09B----1件: 6 💬
211VGN-R09B injection----1件: 323 💬
212VGN-R13----1件: 2 💬
213VHB937----1件: 2 💬
214Viagra1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬3件: 86, 96, 225 💬
215Vialebex----1件: 96 💬
216Viaskin milk 500 MCG----1件: 98 💬
217VIB0551----1件: 13 💬
218VIB4920----2件: 46, 53 💬
219VIB4920 with tnfi----1件: 46 💬
220VIB4920 without tnfi----1件: 46 💬
221VIB7734----4件: 49, 50, 51, 53 💬
222VIB7734, MEDI7734----1件: 49 💬
223Vibrox 100MG capsules----1件: 167 💬
224Video game therapy----1件: 13 💬
225Videofluoroscopic swallow evaluation----1件: 6 💬
226Videofluoroscopic swallowing study----1件: 2 💬
227Vidofludimus1件: Vidofludimus2件: Vidofludimus ,
Vidofludimus calcium 💬 		1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
228Vidofludimus calcium1件: Vidofludimus2件: Vidofludimus ,
Vidofludimus calcium 💬 		1件: DHODH 💬 1件: Pyrimidine metabolism 💬4件: 13, 94, 96, 97 💬
229Vidofludimus calcium dihydrate1件: Vidofludimus2件: Vidofludimus ,
Vidofludimus calcium 💬 		1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 97 💬
230Vigabatrin1件: Vigabatrin1件: Vigabatrin 💬 1件: ABAT 💬 6件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬2件: 145, 158 💬
231Vigabatrin tablets1件: Vigabatrin1件: Vigabatrin 💬 1件: ABAT 💬 6件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
232Vigantol----2件: 13, 65 💬
233Vigantol OEL----1件: 13 💬
234Vigantol OEL TM----2件: 96, 97 💬
235Vigantol OIL----1件: 13 💬
236Vigantol® OIL----1件: 13 💬
237Vigantol® ÖL 20.000 I.E./ML----1件: 13 💬
238Vildagliptin 50 MG BID1件: Vildagliptin1件: Vildagliptin 💬 1件: DPP4 💬 2件: Protein digestion and absorption, Virion - Hepatitis viruses 💬1件: 6 💬
239Vilobelimab1件: Vilobelimab1件: Vilobelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 43, 44, 269 💬
240Viltepso1件: Viltolarsen1件: Viltolarsen 💬 1件: DMD 💬 5件: Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
241Viltolarsen1件: Viltolarsen1件: Viltolarsen 💬 1件: DMD 💬 5件: Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
242Vimovo 250/20----1件: 107 💬
243Vimovo 375/20----1件: 107 💬
244Vimovo 500/20----1件: 107 💬
245Vinblastine1件: Vinblastine2件: Vinblastine sulfate ,
Vinblastine 💬 		9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 34, 63 💬
246Vinblastine sulfate1件: Vinblastine2件: Vinblastine sulfate ,
Vinblastine 💬 		9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 34 💬
247Vinblastine sulphate1件: Vinblastine2件: Vinblastine sulfate ,
Vinblastine 💬 		9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 34 💬
248Vinblastine, vincristine, prednisone, daunorubicin1件: Vinblastine2件: Vinblastine sulfate ,
Vinblastine 💬 		9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 65 💬
249Vincristine1件: Vincristine2件: Vincristine sulfate ,
Vincristine 💬 		9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 26, 331 💬
250Vincristine sulfate1件: Vincristine2件: Vincristine sulfate ,
Vincristine 💬 		9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 26, 34 💬
251Vineuro----1件: 6 💬
252Viokase 16----1件: 298 💬
253Viokase 16 (pancrelipase) + nexium1件: Esomeprazole5件: Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 298 💬
254Viokase® 16----1件: 298 💬
255VIP----3件: 49, 51, 86 💬
256Viral load driven treatment interruption----1件: 265 💬
257Viread - 245 MG 30 compresse rivestite CON film IN flacone USO orale----1件: 46 💬
258Viread 30 CPR 245 MG----1件: 46 💬
259Virtual balance training----1件: 149 💬
260Virtual reality----1件: 6 💬
261Virtual reality group----1件: 13 💬
262VIS171----2件: 49, 222 💬
263VIS649----1件: 66 💬
264Viscous/swallowed budesonide----1件: 98 💬
265Visilizumab1件: Visilizumab1件: Visilizumab 💬 3件: CD3D,
CD3E,
CD3G 💬 		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬2件: 96, 97 💬
266Visilizumab (HUM2911件: Visilizumab1件: Visilizumab 💬 3件: CD3D,
CD3E,
CD3G 💬 		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 97 💬
267Vismodegib1件: Vismodegib1件: Vismodegib 💬 1件: SMO 💬 5件: Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬1件: 85 💬
268Visual biofeedback therapy----1件: 6 💬
269Visual field testing----1件: 19 💬
270VIT C VIT E ZN SE----1件: 113 💬
271VIT D----2件: 63, 227 💬
272VIT-45----1件: 97 💬
273Vital signs----4件: 3, 15, 19, 256 💬
274Vitamin A1件: Vitamin A2件: Vitamin A oil ,
Vitamin A 💬 		2件: RARA,
RARB 💬 		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬3件: 13, 53, 90 💬
275Vitamin AD SIG: 1 tablet/TID----1件: 90 💬
276Vitamin B 6----1件: 234 💬
277Vitamin B SIG: 10MG/TID----1件: 90 💬
278Vitamin B11件: Thiamine3件: Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--2件: 145, 302 💬
279Vitamin B121件: Cyanocobalamin5件: Cyanocobalamin ,
Vitamin B12 ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬 		--2件: 6, 201 💬
280Vitamin B12 supplementation1件: Cyanocobalamin5件: Cyanocobalamin ,
Vitamin B12 ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬 		--1件: 6 💬
281Vitamin B12, B9, B6, C supplementation1件: Cyanocobalamin5件: Cyanocobalamin ,
Vitamin B12 ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬 		--1件: 229 💬
282Vitamin B21件: Riboflavin1件: Riboflavin 💬 --1件: 97 💬
283Vitamin B3----1件: 107 💬
284Vitamin B5 tablets1件: Pantothenic acid3件: Calcium pantothenate ,
Pantothenic acid ,
Sodium pantothenate 💬 		--1件: 97 💬
285Vitamin B6 25 MG1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 6 💬
286Vitamin B6 tablets1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 97 💬
287Vitamin B71件: Biotin1件: Biotin 💬 --1件: 8 💬
288Vitamin C1件: Ascorbic acid1件: Ascorbic acid 💬 --6件: 10, 192, 206, 210, 211, 212 💬
289Vitamin D1件: Vitamin D---20件: 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
290Vitamin D 100UG1件: Vitamin D---1件: 298 💬
291Vitamin D 10UG1件: Vitamin D---1件: 298 💬
292Vitamin D 21件: Vitamin D---1件: 46 💬
293Vitamin D 25(OH)D1件: Vitamin D---1件: 49 💬
294Vitamin D drops1件: Vitamin D---2件: 96, 97 💬
295Vitamin D enriched milk1件: Vitamin D---1件: 97 💬
296Vitamin D IN ARM B1件: Vitamin D---1件: 46 💬
297Vitamin D intake1件: Vitamin D---1件: 46 💬
298Vitamin D measurement1件: Vitamin D---1件: 98 💬
299Vitamin D OIL1件: Vitamin D---1件: 299 💬
300Vitamin D powder1件: Vitamin D---1件: 299 💬
301Vitamin D status1件: Vitamin D---1件: 46 💬
302Vitamin D-32件: Cholecalciferol,
Vitamin D		1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 97 💬
303Vitamin D21件: Ergocalciferol1件: Ergocalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 49, 299 💬
304Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬11件: 6, 13, 20, 46, 49, 51, 53, 65, 96, 97, 299 💬
305Vitamin D3 - high dose1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 6 💬
306Vitamin D3 3000 UI daily1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
307Vitamin D3 400 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
308Vitamin D3 4000 UI daily1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
309Vitamin D3 6000 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
310Vitamin D3 800 UI/DAY then 800 UI/DAY1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
311Vitamin D3: 3000 or 4000 UI/DAY then 2,000 UI/DAY1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
312Vitamin E1件: Vitamin E1件: Vitamin E 💬 --5件: 2, 19, 20, 90, 206 💬
313Vitamin E - tgps1件: Vitamin E1件: Vitamin E 💬 --1件: 299 💬
314Vitamin E 800IU1件: Vitamin E1件: Vitamin E 💬 --2件: 96, 97 💬
315Vitamin E supplement1件: Vitamin E1件: Vitamin E 💬 --1件: 317 💬
316Vitamin K1件: Phylloquinone1件: Phytonadione 💬 --3件: 13, 46, 97 💬
317Vitamin K 10 MG1件: Phylloquinone1件: Phytonadione 💬 --2件: 96, 97 💬
318Vitamin K cream1件: Phylloquinone1件: Phytonadione 💬 --1件: 13 💬
319Vitamin K supplementation, dose #11件: Phylloquinone1件: Phytonadione 💬 --1件: 299 💬
320Vitamin K supplementation, dose #21件: Phylloquinone1件: Phytonadione 💬 --1件: 299 💬
321Vitamin K11件: Phylloquinone1件: Phytonadione 💬 --1件: 96 💬
322Vitamin K1 tablets1件: Phylloquinone1件: Phytonadione 💬 --1件: 46 💬
323Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1----1件: 299 💬
324Vitamina A----1件: 28 💬
325Vitamina D3 kern pharma soluciÓN oleosa----1件: 13 💬
326Vitamins: B6, B12, and folate----1件: 49 💬
327Viusid/alzer----1件: 6 💬
328Vivaglobin----2件: 14, 65 💬
329Vivigen cellular bone matrix----1件: 70 💬
330Vivomixx probiotics----1件: 51 💬
331Vixarelimab1件: Vixarelimab1件: Vixarelimab 💬 1件: OSMR 💬 3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, PI3K-Akt signaling pathway 💬3件: 51, 85, 97 💬
332Vizamyl----3件: 5, 7, 127 💬
333VK02141件: VK-0214---1件: 20 💬
334VM106----1件: 65 💬
335VM202----1件: 2 💬
336VNX001----1件: 226 💬
337VNZ/TEZ/D-IVA----1件: 299 💬
338VO4CX----1件: 296 💬
339VO6591件: VO659---1件: 8 💬
340Vobarilizumab1件: Vobarilizumab1件: Vobarilizumab 💬 --1件: 49 💬
341VOC probiotic----1件: 294 💬
342Voclosporin1件: Voclosporin1件: Voclosporin 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 49, 222 💬
343Voice, speech and language analysis----1件: 6 💬
344Volanesorsen1件: Volanesorsen2件: Volanesorsen ,
Volanesorsen sodium 💬 		1件: APOC3 💬 2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
345Volanesorsen sodium, APOC-III antisense oligonucleotide1件: Volanesorsen2件: Volanesorsen ,
Volanesorsen sodium 💬 		1件: APOC3 💬 2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
346Volibris1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 51, 85, 86, 88 💬
347Volibris 10 MG comprimidos recubiertos CON PELícula1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
348Volibris 5 MG comprimidos recubiertos CON PELícula1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
349Volibris™ tablets1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
350Volixibat1件: Volixibat2件: Volixibat potassium ,
Volixibat 💬 		--2件: 93, 94 💬
351Volixibat potassium1件: Volixibat2件: Volixibat potassium ,
Volixibat 💬 		--2件: 93, 94 💬
352Voltaren resinat----1件: 271 💬
353Voltarol SR----1件: 46 💬
354Voltrarol SR----1件: 46 💬
355Voluntary cough test----1件: 6 💬
356Voluntary peak cough flow testing----1件: 2 💬
357VON willebrand factor1件: Von Willebrand factor human---2件: 63, 288 💬
358VON willebrand factor and coagulation factor viii IN combination1件: Von Willebrand factor human---1件: 288 💬
359VON willebrand factor antigen1件: Von Willebrand factor human---1件: 288 💬
360VON willebrand factor concentrates and factor viii concentrates1件: Von Willebrand factor human---1件: 288 💬
361VON willebrand factor ristocetin cofactor1件: Von Willebrand factor human---1件: 288 💬
362VON willebrand faktor----1件: 288 💬
363Vonafexor1件: Vonafexor---1件: 218 💬
364Voncento2件: Antihemophilic factor human,
Von Willebrand factor human		---1件: 288 💬
365Vonicog alfa1件: Vonicog alfa1件: Vonicog alfa 💬 --1件: 288 💬
366Vonoprazan1件: Vonoprazan1件: Vonoprazan 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬3件: 63, 97, 98 💬
367Voriconazole1件: Voriconazole1件: Voriconazole 💬 --2件: 60, 299 💬
368Vorinostat1件: Vorinostat1件: Vorinostat 💬 11件: HDAC10,
HDAC11,
HDAC1_2,
HDAC1_2,
HDAC3,
HDAC4_5,
HDAC4_5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		20件: ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬2件: 75, 96 💬
369Vorsoritide----1件: 276 💬
370Vortioxetina bromidrato1件: Vortioxetine2件: Vortioxetine ,
Vortioxetine hydrobromide 💬 		7件: HTR1,
HTR3,
HTR3,
HTR3,
HTR3,
HTR3,
SLC6A4 💬 		6件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
371Vortioxetine1件: Vortioxetine2件: Vortioxetine ,
Vortioxetine hydrobromide 💬 		7件: HTR1,
HTR3,
HTR3,
HTR3,
HTR3,
HTR3,
SLC6A4 💬 		6件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 6, 127 💬
372Vosoritide1件: Vosoritide1件: Vosoritide 💬 1件: NPR2 💬 5件: Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 19, 276 💬
373Vosoritide injection1件: Vosoritide1件: Vosoritide 💬 1件: NPR2 💬 5件: Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 195 💬
374Votubia1件: Everolimus1件: Everolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 34, 158 💬
375Voxzogo1件: Vosoritide1件: Vosoritide 💬 1件: NPR2 💬 5件: Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 276 💬
376VP 20624----1件: 65 💬
377VP-001----1件: 90 💬
378VPA----1件: 3 💬
379VPD-737----1件: 36 💬
380Vpriv1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
381Vpriv - 400 U - polvere PER soluzione PER infusione - USO endovenoso - flaconcino(vetro) 1 flaconcino1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
382Vpriv 400 units powder FOR solution OF infusion1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
383VR040----1件: 6 💬
384VR040/aspirair® inhaler----1件: 6 💬
385VR496----1件: 299 💬
386VRG50635----1件: 2 💬
387VRP700----1件: 85 💬
388VRT-813077----1件: 299 💬
389VRT-826809----1件: 299 💬
390VRT-893661----1件: 299 💬
391VRT-893661 VRT-0893661----1件: 299 💬
392VSA003----1件: 79 💬
393VSL#3----4件: 96, 97, 107, 291 💬
394VSN16R----1件: 13 💬
395VSN16R 100MG----1件: 13 💬
396VT-001----1件: 66 💬
397VTS-270----1件: 19 💬
398VTX-8011件: VTX-801---1件: 171 💬
399VTX-958----1件: 96 💬
400VTX002----1件: 97 💬
401VTX002 IS NOT biologic----1件: 97 💬
402VTX2735----1件: 106 💬
403VTX3232----1件: 6 💬
404VTX958----1件: 96 💬
405VUM02 injection----1件: 85 💬
406Vunakizumab1件: Vunakizumab---2件: 49, 51 💬
407Vutiglabridin1件: Vutiglabridin---1件: 6 💬
408Vutrisiran1件: Vutrisiran2件: Vutrisiran sodium ,
Vutrisiran 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
409VWD factor viii concentrate----1件: 288 💬
410VWF gene analysis----1件: 288 💬
411VWF replacement therapy with wilate----1件: 288 💬
412VWF SD-35-DH----1件: 288 💬
413VWF-containing products----1件: 288 💬
414VWF/fviii products----1件: 288 💬
415VX-118----1件: 299 💬
416VX-1211件: Vanzacaftor1件: Vanzacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
417VX-121/TEZ/D-IVA1件: Vanzacaftor1件: Vanzacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
418VX-121/tezacaftor/deutivacaftor3件: Deutivacaftor,
Tezacaftor,
Vanzacaftor		3件: Tezacaftor ,
Deutivacaftor ,
Vanzacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
419VX-147----1件: 222 💬
420VX-152----1件: 299 💬
421VX-371----2件: 299, 340 💬
422VX-371 % 0,17% nacl----1件: 340 💬
423VX-371 / 0.17% nacl----1件: 340 💬
424VX-371 / 4,2% nacl----1件: 340 💬
425VX-371 / 4.2% nacl----1件: 340 💬
426VX-371 IN hypertonic saline----1件: 299 💬
427VX-371 IN saline----1件: 299 💬
428VX-407----1件: 67 💬
429VX-440----1件: 299 💬
430VX-445----1件: 299 💬
431VX-445 / TEZ / IVA----1件: 299 💬
432VX-445 / TEZ / IVA FDC----1件: 299 💬
433VX-445 /TEZ/IVA----1件: 299 💬
434VX-445/TEZ/IVA----1件: 299 💬
435VX-509----1件: 46 💬
436VX-522 mrna therapy----1件: 299 💬
437VX-561----1件: 299 💬
438VX-634----1件: 231 💬
439VX-659----1件: 299 💬
440VX-659/ TEZ/IVA----1件: 299 💬
441VX-659/TEZ/IVA----1件: 299 💬
442VX-659/tezacaftor/ivacaftor2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
443VX-661----1件: 299 💬
444VX-661 / VX-770----1件: 299 💬
445VX-661 plus ivacaftor combination1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
446VX-661, VRT-893661----1件: 299 💬
447VX-661/ivacaftor1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
448VX-661/ivacaftor (VX-770) 100MG/150 MG1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
449VX-661/ivacaftor 100 MG/ 150 MG1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
450VX-661/ivacaftor 100MG/150 MG1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
451VX-661/ivacaftor 100MG/150MG1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
452VX-661/ivacaftor 50 MG/ 75 MG1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
453VX-661/VX-770----1件: 299 💬
454VX-668----1件: 231 💬
455VX-670----1件: 113 💬
456VX-7021件: VX-702---1件: 46 💬
457VX-745----1件: 8 💬
458VX-7651件: VX-765---1件: 106 💬
459VX-77----1件: 299 💬
460VX-770----2件: 299, 340 💬
461VX-770, VRT-8130077----1件: 299 💬
462VX-770, VRT-813077----1件: 299 💬
463VX-809----1件: 299 💬
464VX-809 & VX-770----1件: 299 💬
465VX-809 / VX-770----1件: 299 💬
466VX-809, VRT-826809----1件: 299 💬
467VX-809/VX-770----1件: 299 💬
468VX-814----1件: 231 💬
469VX-828----1件: 299 💬
470VX-864----1件: 231 💬
471VX147----1件: 222 💬
472VX15/2503----2件: 8, 13 💬
473VX864----1件: 231 💬
474VY-AADC01----1件: 6 💬
475VY-AADC02----1件: 6 💬
476Vyndaqel----1件: 28 💬
477Vyndaqel 20MG soft capsule1件: Tafamidis2件: Tafamidis ,
Tafamidis meglumine 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
478VYNT-0126----1件: 156 💬
479Vyondys 531件: Golodirsen1件: Golodirsen 💬 1件: DMD 💬 5件: Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬